Trial Profile
Effects of alendronate and denosumab on glucocorticoid-induced osteoporosis by a randomized, open-labeled study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Oct 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Alendronic acid; Alfacalcidol
- Indications Corticosteroid-induced osteoporosis
- Focus Therapeutic Use
- 10 Nov 2015 New trial record